MBIO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Mindbio Therapeutics Corp. engages in the provision of developing psychedelic medicines to treat medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. The company was founded by Justin Hanka in 2020 and is headquartered in Melbourne, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MBIO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company